Pharmaceutical care for anti-infectious treatment of febrile neutropenia:a case report

SHEN Shaoqing; REN Haoyang

doi:10.3969/j.issn.1006-0111.2016.04.021

Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review, editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name

E-mail

Phone

Title

Content

Verification Code

Objective To discuss the pharmaceutical care experience of the clinical pharmacist in anti-infectious treatment of one patient with febrile neutropenia. Methods The clinical pharmacists participated in the treatment of the patient with febrile neutropenia. According to the patient's laboratory indices and vital signs, the pharmacist assisted clinicians to formulate the anti-infection regimen, recommend for rational use of drugs, carried out drug education to the patient, and track drug efficacy and adverse drug reactions (ADR). Results The patient's infection was well controlled and effectively avoid the occurrence of ADR. Conclusion With pharmaceutical care through clinical pharmacists, infection in the patient with febrile neutropenia would be controlled, the patient's life quality could be improved.

Pharmaceutical care for anti-infectious treatment of febrile neutropenia:a case report

Department of Pharmacy, Hainan Branch of PLA General Hospital, Sanya 572013, China

Received Date: 2015-04-09

Rev Recd Date: 2015-09-18

Key words:

Abstract: Objective To discuss the pharmaceutical care experience of the clinical pharmacist in anti-infectious treatment of one patient with febrile neutropenia. Methods The clinical pharmacists participated in the treatment of the patient with febrile neutropenia. According to the patient's laboratory indices and vital signs, the pharmacist assisted clinicians to formulate the anti-infection regimen, recommend for rational use of drugs, carried out drug education to the patient, and track drug efficacy and adverse drug reactions (ADR). Results The patient's infection was well controlled and effectively avoid the occurrence of ADR. Conclusion With pharmaceutical care through clinical pharmacists, infection in the patient with febrile neutropenia would be controlled, the patient's life quality could be improved.

HTML

Reference (12)

[1]	中华医学会血液学分会,中国医师协会血液科医师分会.2012年中国中性粒细胞缺乏伴发热患者抗菌药物临床应用指南[J]. 中华血液学杂志,2012,33(8):693-696.
[2]	王舒莉,崔渤莉,孟月生,等. 恶性血液病患者血流感染病原菌特点及危险因素分析[J]. 中华医院感染学杂志,2014,24(13):3182-3184.
[3]	石业队. 泰能的不良反应概述[J].齐齐哈尔医学院学报,2010,31(7):1105-1106.
[4]	伍万,江荣林,马伟斌,等. ICU肠球菌属血流感染危险因素及药敏分析[J]. 中华医院感染学杂志,2014,24(6):1367-1369.
[5]	朱任媛,张小江,徐英春,等. 2012年中国CHINET无菌体液中分离的细菌构成和耐药性监测[J]. 中国感染与化疗杂志,2014,14(6):482-487.
[6]	陈超,郭代红,王东晓,等. 利奈唑胺相关性血小板减少的主动监测研究[M]. 中国药物应用与监测,2014,11(1):22-25.
[7]	French G. Safety and tolerability of linezolid[J]. J Antimicrob Chemother, 2003,51(2):45-53.
[8]	Ramsey TD, Lau TT, Ensom MH. Serotonergic and adrenergic drug interactions associated with linezolid:a critical review and practical management approach[J]. Ann Pharmacother, 2013,47(4):543-560.
[9]	韩孟锋,于海杰. 静脉滴注头孢哌酮钠舒巴坦钠后饮酒致双硫仑样反应1例[J]. 中国实用乡村医生杂志,2014,23(23):55.
[10]	王书会,王静娜,王海燕,等. 急性白血病患者医院感染影响因素调查研究[J]. 中华医院感染学杂志,2014,24(21):5333-5335.
[11]	刘彤华. 粒细胞缺乏患者发热原因及治疗分析[J]. 山东医药,2014,54(32):90-91.
[12]	罗洪强,傅佳萍,蒋景华. 恶性血液病患者医院感染危险因素及预防控制研究[J]. 中华医院感染学杂志,2014,24,(5):1171-1173.

Message Board

Pharmaceutical care for anti-infectious treatment of febrile neutropenia:a case report

doi: 10.3969/j.issn.1006-0111.2016.04.021

Abstract

References

Proportional views

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Related

Proportional views